In this study, we uncovered a novel mechanism of promotion of anti-tumor immunity by miR-128 through regulating the ZEB1/CD47 axis, thus linking an EMT regulatory program to anti-tumor immunity in PDAC. This evidence concerns the gene CD47 and neoplasm.